AGP Executive Report
Last update: 9 hours agoEU Cancer Care: Sanofi’s Sarclisa (isatuximab) gets EU approval for subcutaneous use via an on-body injector, aiming to cut repeated clinic visits for multiple myeloma patients. Health Tech & Diagnostics: ABL Diagnostics plans HybridChek, bringing hybrid capture and amplicon sequencing under one platform for HIV and tuberculosis whole-genome sequencing. Clinical Innovation: A four-week UK trial finds that counting one daily serving of 100% fruit juice toward “5-a-day” can boost fruit intake without short-term worsening in blood markers, and may improve depression scores. Public Health & Food Safety: A French Caribbean legacy story highlights health impacts from chlordecone contamination, linking it to high prostate cancer rates. Digital Health Governance: EU moves to restrict US cloud providers from sensitive government contracts, with healthcare among the targeted critical workloads. Mental Health & Lifestyle: Research and commentary continue to spotlight diet, mood, and the role of accessible nutrition choices. France in the Spotlight: Ticketmaster pauses Céline Dion Paris ticket sales after “suspicious activity,” affecting fans’ access to events.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Value Based Healthcare Market Size Will Surpass USD 12.48 Billion by 2034 Growing at 11.75% CAGR - Exclusive Report by ZMR | Global Value Based Healthcare Market Size, Share, Trends Analysis Report](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/18574987-652842201-zion-market-research-jpg-100x100.jpeg)
